Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: J Subst Abuse Treat. 2010 Jun;38(Suppl 1):S4–13. doi: 10.1016/j.jsat.2010.01.011

Table 2.

STATUS OF CTN RANDOMIZED, CONTROLLED CLINICAL TRIALS (Fall 2009)

Protocol #
(Referenceb)
Study CTPs N Statusa
CTN 0001 Buprenorphine/naloxone for inpatient detoxification 6 113 Completed (Ling, et al., 2005)
CTN 0002 Buprenorphine/naloxone for outpatient detoxification 6 230 Completed (Ling, et al., 2005)
CTN 0003 Comparison of two buprenorphine/naloxone taper schedules 11 516 Completed (Ling, et al., 2009)
CTN 0004 Motivational enhancement therapy for patients in treatment for substance use disorders 6 496 Completed (Ball, et al., 2007)
CTN 0005 Motivational interviewing for patients in treatment for substance use disorders 5 423 Completed (Carroll, et al., 2006)
CTN 0006 Low cost motivational incentives for stimulant-abusing patients in outpatient psychosocial treatment programs 8 454 Completed
(Petry, et al., 2005)
CTN 0007 Low cost motivational incentives for stimulant-abusing patients in methadone maintenance treatment 6 403 Completed (Peirce, et al., 2006)
CTN 0009 Incorporating smoking cessation treatment into substance abuse treatment programs 12 225 Completed (Reid, et al., 2008)
CTN 0010 Buprenorphine/naloxone-facilitated rehabilitation for opioid-dependent adolescents and young adults 6 154 Completed (Woody, et al., 2008)
CTN 0011 Telephone enhancement procedure for long-term engagement in continuing care 4 339 Completed (Hubbard, et al., 2007)
CTN 0013 Motivational enhancement therapy for pregnant women in treatment for substance use disorders 4 200 Completed (Winhusen, et al., 2008)
CTN 0014 Brief Strategic Family Therapy for adolescents in treatment for substance use disorders 8 457 Manuscript in Preparation
CTN 0015 Seeking Safety therapy for women with PTSD in treatment for substance use disorders 7 353 Completed (Hien, et al., 2009)
CTN0017 HIV HCV risk reduction interventions for injection substance users 8 632 Manuscript in Preparation
CTN 0018 HIV/STD risk reduction interventions for men in treatment for substance use disorders 14 594 Completed (Calsyn, et al., 2009)
CTN 0019 HIV/STD risk reduction interventions for women in treatment for substance use disorders 12 517 Completed (Tross, et al., 2008)
CTN 0020 Job seekers training for patients in treatment for substance use disorders 12 628 Manuscript in Preparation
CTN 0021 Motivational enhancement therapy for Spanish-speaking patients in treatment for substance use disorders 6 463 Completed (In
Press)
CTN 0027 Liver function in patients maintained on buprenorphine/naloxone or methadone 9 1269 Follow-up
CTN 0028 Osmotic-release methylphenidate for ADHD in adolescents in treatment for substance use disorders 11 303 Manuscript in Preparation
CTN 0029 Osmotic-release methylphenidate for ADHD in patients receiving smoking cessation treatment 6 255 Completed (In Press)
CTN 0030 Treatment of prescription opioid addiction 11 648 Follow-up
CTN 0031 Twelve-step engagement for patients in treatment for stimulant use disorders 10 471 Follow-up
CTN 0032 HIV rapid testing and counseling in substance abuse treatment programs 12 1281 Follow-up
CTN 0037 Exercise as an adjunctive treatment for substance use disorders 10c 330c Protocol Development
CTN 0044 Web-delivered treatment for substance use disorders 10c 500c Protocol Development
CTN 0046 Smoking cessation intervention for patients in treatment for stimulant use disorders 12c 528c Protocol Development
a

Status terminology

Completed: All protocol-defined research is finished and the primary paper has been accepted

Manuscript in preparation: All protocol-defined research is finished and the primary paper is in process

Follow-up: Participant enrollment is finished. Participant follow-up is ongoing.

b

See Reference section for full citation

c

Planned study parameters